Memantine Hydrochloride Tablet
Product Images NDC 72578-003

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 72578-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viona Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 01)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 02)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 03)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 04)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 05)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 06)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 07)

The text provides a graph showing the cumulative percentage of patients related to two different drugs: Placobol/Donopozil and M.HClDonepezil. It also shows a line graph representing the change from Baseline score for the Alzheimer's Disease Cooperative Study-Activities of Daily Living Scale (ADCS-ADL) with a value of 25.*

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 08)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 09)

This is a graph that shows the cumulative percentage of patients and their SIB (Severe Impairment Battery) change from baseline while taking either a placebo or Donepezil (M HCI) medication. The graph shows that the patients taking Donepezil had a higher percentage of positive SIB changes compared to those on the placebo.*

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 10)

FDA Label Image

Memantine Hydrochloride Tablets (5b56b880 7a88 4d48 8291 96f38c791808 11)

Memantine Hydrochloride is a medication available in tablet form with each tablet containing 10mg of the compound. The medication is Rx-only and should be dispensed along with Patient Information by the attending pharmacist according to guidelines provided in the package insert. The tablets must be stored in a controlled room temperature and kept out of children's reach. They are packaged in a container size of 60 tablets. The manufacturer is Cadia Healthcare Limited, located in India, and the distributor is Vona Pharmaceuticals, based in Maryland, USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.